TY - JOUR
T1 - Exhaustion and senescence
T2 - two crucial dysfunctional states of T cells in the tumor microenvironment
AU - Zhao, Yangjing
AU - Shao, Qixiang
AU - Peng, Guangyong
N1 - Funding Information:
Because of space limitations, we apologize to anyone whose excellent studies have been inadvertently omitted. This work was partially funded by grants from the American Cancer Society (RSG-10-160-01-LIB, to G.P.), Melanoma Research Alliance (to G.P.), and NIH (AI097852, AI094478, and CA184379 to G.P.).
Publisher Copyright:
© 2019, CSI and USTC.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - The failure of a massive influx of tumor-infiltrating T lymphocytes to eradicate tumor cells in the tumor microenvironment is mainly due to the dysfunction of T cells hyporesponsive to tumors. T-cell exhaustion and senescence induced by malignant tumors are two important dysfunctional states that coexist in cancer patients, hindering effective antitumor immunity and immunotherapy and sustaining the suppressive tumor microenvironment. Although exhausted and senescent T cells share a similar dysfunctional role in antitumor immunity, they are distinctly different in terms of generation, development, and metabolic and molecular regulation during tumor progression. Here, we discuss the unique phenotypic and functional characteristics of these two types of dysfunctional T cells and their roles in tumor development and progression. In addition, we further discuss the potential molecular and metabolic signaling pathways responsible for the control of T-cell exhaustion and senescence in the suppressive tumor microenvironment. Understanding these critical and fundamental features should facilitate rethinking the unresponsiveness to current immunotherapies in clinical patients and lead to further development of novel and effective strategies that target different types of dysfunctional T cells to enhance cancer immunotherapy.
AB - The failure of a massive influx of tumor-infiltrating T lymphocytes to eradicate tumor cells in the tumor microenvironment is mainly due to the dysfunction of T cells hyporesponsive to tumors. T-cell exhaustion and senescence induced by malignant tumors are two important dysfunctional states that coexist in cancer patients, hindering effective antitumor immunity and immunotherapy and sustaining the suppressive tumor microenvironment. Although exhausted and senescent T cells share a similar dysfunctional role in antitumor immunity, they are distinctly different in terms of generation, development, and metabolic and molecular regulation during tumor progression. Here, we discuss the unique phenotypic and functional characteristics of these two types of dysfunctional T cells and their roles in tumor development and progression. In addition, we further discuss the potential molecular and metabolic signaling pathways responsible for the control of T-cell exhaustion and senescence in the suppressive tumor microenvironment. Understanding these critical and fundamental features should facilitate rethinking the unresponsiveness to current immunotherapies in clinical patients and lead to further development of novel and effective strategies that target different types of dysfunctional T cells to enhance cancer immunotherapy.
KW - Checkpoint blockade
KW - Exhaustion
KW - Inhibitory receptor
KW - Metabolism
KW - Senescence
KW - T-cell dysfunction
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85076905629&partnerID=8YFLogxK
U2 - 10.1038/s41423-019-0344-8
DO - 10.1038/s41423-019-0344-8
M3 - Review article
C2 - 31853000
AN - SCOPUS:85076905629
SN - 1672-7681
VL - 17
SP - 27
EP - 35
JO - Cellular and Molecular Immunology
JF - Cellular and Molecular Immunology
IS - 1
ER -